4Pozio E, Gomez Morals MA, Dupouy - Camet J. Clinical aspects, di- agnosis and treatment of trichinellosis. Expert Rev Anti Infect Ther, 2003,1:471 -482.
5Watt G, Silachamroon U. Areas of uncertainty in the management of human trichinellosis:a clinical perspective. Expert Rev Anti Infect T- her,2004,2:649 - 652.
6Enarson DA. Children and the global tuberculosis situation[ J ]. Paediatr Respir Rev,2004,5 (suppl A) :143-145.
7Pablos MA,Blumstein J, Knirsch CA. The role of diabetes metlitus in the higher prevalence of tuberculosis among Hispanics[ J]. Am J Public Health, 1997,87 (4) :574-579.
8Kent S J, Crowe SM, Yung A, et al. Tuberculous meningitis : a 30 year review [ J ]. Clin Infect Dis, 1993,17 ( 6 ) :987-994.
9Bargallo J, Berenguer J, Garcia B J, et al. The " target sign" : Is it a specific sign of CNS tuberculoma [ J ] ? Neuroradiology, 1996,58 (6) :547-550.
10Gautam N, Aryal M, Bhatta N, et al. Comparative study of cerebrospinal fluid adenosine deaminase activity in patients with meningitis [J]. Nepal Med Coll J,2007,9(2) :104-106.
